View Older Stories View More Recent Stories
-
Medallia, Inc. (MDLA) Announces Proposed 14.5M Share IPO
-
Medallia Announces Launch of Initial Public Offering
-
NetworkNewsBreaks – ROTH Capital Partners to Host RNA Revolution Conference in New York City
-
NetworkNewsBreaks – ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) Closes $15.6M Underwritten Public Offering
-
NetworkNewsBreaks – Akero Therapeutics, Inc. (NASDAQ: AKRO) Closes $105.8 Million IPO
-
NetworkNewsBreaks – ArQule, Inc. (NASDAQ: ARQL) Closes $103.7M Follow-On
-
Charles & Colvard, Ltd. Announces Underwriters’ Exercise of Over-Allotment Option
-
Arcimoto Inc. (FUV) PT Lowered to $7 at Roth Capital
-
Tesla shares jump as record deliveries ease demand concerns
-
Roth Capital Reiterates Buy Rating on Amarin Corporation (AMRN)
-
PlayAGS, Inc. (AGS) New Cabinets Outperforming, Reit Buy At Roth
-
Silvercrest Asset Management Group Acquires Cortina Asset Management
-
Roth Capital Downgrades Ballard Power Systems (BLDP) to Sell
-
ROTH Capital Partners to Host ROTH RNA Revolution Conference in New York City on July 17th, 2019
-
Highpower International (HPJ) to Be Acquired by Consortium in Going Private Transaction Valued at $4.80/Share
-
Highpower International Enters Into Definitive Agreement to Be Acquired by Consortium in Going Private Transaction
-
Roth Capital Starts Merus N.V. (MRUS) at Buy
-
ArQule Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
-
Acer Therapeutics (ACER) PT Lowered to $9 at Roth Capital
-
NetworkNewsBreaks – SharpSpring, Inc. (NASDAQ: SHSP) Closes $26.7M Secondary Public Offering
-
Roth Capital Reiterates Buy Rating on Eldorado Resorts (ERI)
-
Roth Capital Downgrades PCM, Inc (PCMI) to Neutral Following Acquisition
-
Roth Capital Starts SharpSpring Inc (SHSP) at Buy
-
ArQule (ARQL) Prices 9.25M Share Common Offering at $9.75/Sh
-
ArQule Announces Pricing of $90 Million Public Offering of Common Stock
-
Akero Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
-
Roth Capital Downgrades Shopify (SHOP) to Neutral
-
Roth Capital Upgrades Renewable Energy Group (REGI) to Buy
-
Akero Therapeutics (AKRO) IPO Opens Essentially Flat
-
Akero Therapeutics, Inc. (AKRO) Prices 5.75M Share IPO at $16/Sh
-
Cryoport (CYRX) Prices 3.75M Share Common Offering at $17/Sh
-
Akero Therapeutics Announces Pricing of Initial Public Offering
-
Cryoport Announces Pricing of Public Offering of Common Stock
-
UPDATE: Roth Capital Downgrades QuickLogic (QUIK) to Neutral
-
ContraVir Pharma (CTRV) Prices Public Offering with Expected Total Gross Proceeds of Approx. $15.6M
-
ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering
-
UPDATE: Roth Capital Starts Translate Bio (TBIO) at Buy
-
Roth Capital Starts Synchronoss Technologies (SNCR) at Buy
-
Evercel Announces Sale of Investment in SharpSpring
-
SharpSpring Announces Closing of Secondary Public Offering by Selling Stockholders
-
Soliton (SOLY) Reports $9.45 Million Private Placement of Common Stock, Warrants
-
Soliton Announces $9.45 Million Private Placement
-
Roth Capital Starts Amarin Corporation (AMRN) at Buy
-
W&T Offshore (WTI) PT Lowered to $9.50 at Roth Capital
-
Mohawk Group Holdings, Inc. Closes Its Initial Public Offering
-
Callon Petroleum (CPE) PT Lowered to $12 at Roth Capital
-
ArQule (ARQL) PT Raised to $13 at Roth Capital
-
NetworkNewsBreaks – Charles & Colvard Ltd. (NASDAQ: CTHR) Secures $10M in Underwritten Public Offering
-
UPDATE: Roth Capital Starts AquaVenture Holdings (WAAS) at Buy
-
Callaway Golf (ELY) PT Raised to $19 at Roth Capital

